Pancreatic Incidentalomas: High Rate of Potentially Malignant Tumors

Department of Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Journal of the American College of Surgeons (Impact Factor: 5.12). 09/2009; 209(3):313-9. DOI: 10.1016/j.jamcollsurg.2009.05.009
Source: PubMed


Pancreatic incidentaloma (PI) is an increasingly common diagnosis that has received little attention. We characterized these tumors and compared them with symptomatic pancreatic tumors (nonincidentaloma [NI]).
A retrospective database of 475 consecutive pancreatectomies that were performed from January 1995 to June 2007 at our institution was analyzed. Data for PI and NI patient cohorts were compared.
Sixty-four PIs (13.5%) and 411 NIs (86.5%) were identified; 21% of pancreatic body and tail tumors versus 9% of tumors located in the pancreatic head were incidentally diagnosed (p = 0.001). Twenty-two PIs (34%) versus 278 NIs (67%) were malignant (p < 0.0001), 38 PIs (60%) were premalignant, and the remaining 4 (6%) had little or no risk for malignant progression. Intrapapillary mucinous cystic tumor was the most common diagnosis in the PI group (23.4%, n = 15). Of these, 13.3% (n = 2) were invasive versus 40.6% (n = 15) in the NI group (p = 0.02). Likewise, pathologic features for ductal adenocarcinomas were more favorable in PI versus NI tumors. Overall, PI patients had prolonged median disease-specific survival: 145 versus 46 months (p = 0.001). Median disease-specific survival for PI versus NI patients treated for adenocarcinoma were 22 versus 19 months, respectively (p = 0.4); 5-year disease-specific survival for PI versus NI patients treated for intrapapillary mucinous cystic tumor/mucinous cystadenoma were 94% versus 68%, respectively (p = 0.07).
Operation for PI is common, and a substantial proportion of these lesions might be malignant or premalignant. Resection of these early tumors in asymptomatic individuals is associated with improved survival, as compared with patients with symptomatic disease.

Download full-text


Available from: Richard Nakache, Oct 05, 2014
34 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this paper, we report the pulse width measurement of the 27th harmonic having a photon energy of 42 eV, which is the highest photon energy inducing nonlinear process, by autocorrelation technique. The two-photon double ionization of He is used as the nonlinear process for autocorrelation. The pulse duration of 8 fs is obtained with the pump pulse of 20 fs.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: MRI is widely used as the imaging of choice for spinal disorders and may reveal either a clinically insignificant incidental abnormality or a significant lesion, unrelated to the spine, which may explain the patient's symptoms. This article attempts to establish the importance of such findings and describes a sensible approach to the reporting of MRI examinations of the spine with special attention to the incidental findings commonly encountered. The MRI characteristics of such findings are briefly described.
    Clinical Radiology 05/2009; 64(4):353-61. DOI:10.1016/j.crad.2008.09.010 · 1.76 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In pancreatic cancer management progress has been made in the understanding of the disease on a molecular biological level and modalities for early diagnosis of pancreatic cancer have improved as well as the medical and surgical treatment strategies with curative, adjuvant and palliative aims. Realistic expectations for an earlier and more accurate diagnosis of pancreatic cancer – and thereby better treatment results – are constituted by the development of new blood tests and functional imaging. Adjuvants and neoadjuvants are presumed to be more effective and tolerable already in the near future, making the extended surgery more meaningful. On the same time, minimally invasive local treatments and laparoscopic resections are under development, eventually combined with localized growth factor treatment. One of the most important issue for improved clinical and oncological results is the centralization of complex resective procedures to few surgical centers, not due to the need of surgical skills but for an experienced team treatment approach during the operative and postoperative course. Finally, adjuvant treatment with pancreatic stem cells after curatively intended surgical resections is already on its way.
    Viszeralmedizin / Visceral Medicine 01/2010; 26(2):116-121. DOI:10.1159/000313822 · 0.10 Impact Factor
Show more